Formulary

 

DEPARTMENT OF HEALTH
Board of Medicine

RULE NO: RULE TITLE
64B8-30.008: Formulary

NOTICE OF CORRECTION

Notice is hereby given that the following correction has been made to the proposed rule in Vol. 35 No. 15, April 17, 2009 issue of the Florida Administrative Weekly. Although the rule notice stated that a Statement of Estimated Regulatory Costs (SERC) had been prepared and was available, the notice did not summarize the SERC. The following is a Summary of the Statement of Estimated Regulatory Costs:

1. The proposed change will allow Physician Assistants (PAs) to prescribe antipsychotics and parenteral preparations.

2. This rule change may affect up to 4,321 PAs and the physicians that supervise them.

3. The rule change will not require any government entity to incur additional costs or receive additional revenues.

4. No transactional costs will be incurred by any person or entity affected by this rule revision.

5. This proposed rule revision will have a positive impact on physician offices because it will expand access to direct patient care.

This correction does not affect the substance of the rule as it appeared in the Florida Administrative Weekly as outlined above.

THE PERSON TO BE CONTACTED REGARDING THIS RULE IS: Larry McPherson, Jr., Executive Director, Board of Medicine, 4052 Bald Cypress Way, Bin #C03, Tallahassee, Florida 32399-3253